However, the detailed molecular mechanisms of the ASIC1 oncogenic effects in lung adenocarcinoma as well as the prospects of the selective ASIC1 targeting for lung cancer therapy remain unclear. This evidence concerns the gene ASIC1 and lung adenocarcinoma.